Additive effects of a small molecular PCNA inhibitor PCNA-I1S and DNA damaging agents on growth inhibition and DNA damage in prostate and lung cancer cells
Shan Lu(University of Cincinnati Medical Center), Zhongyun Dong(University of Cincinnati Medical Center)
Cited by 24
Related Papers
Small-Molecule Targeting of Proliferating Cell Nuclear Antigen Chromatin Association Inhibits Tumor Cell Growth
|Molecular Pharmacology|2012|102
Secretory phospholipase A2-IIa is involved in prostate cancer progression and may potentially serve as a biomarker for prostate cancer
|Carcinogenesis|2010|92
Vav3 Oncogene Is Overexpressed and Regulates Cell Growth and Androgen Receptor Activity in Human Prostate Cancer
|Molecular Endocrinology|2006|81
Secretory phospholipase A2-IIa upregulates HER/HER2-elicited signaling in lung cancer cells
|International Journal of Oncology|2014|34
Target validation and structure–activity analysis of a series of novel <scp>PCNA</scp> inhibitors
|Pharmacology Research & Perspectives|2015|25